The use of oral contraceptive is inversely associated with the risk of type 2 diabetes mellitus among middle-aged women

References

• Mosher WD, Jones J. Use of contraception in the United States: 1982–2008. Vital Health Stat. 2010;29:1–44.
   Google Scholar
• Alkema L, Kantorova V, Menozzi C, et al. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet. 2013;381(9878):1642–1652.
   PubMed Web of Science ®Google Scholar
• Burkman RT, Collins JA, Shulman LP, et al. Current perspectives on oral contraceptive use. Am J Obstet Gynecol. 2001;185(2 Suppl):S4–S12.
   PubMed Web of Science ®Google Scholar
• Jensen JT, Speroff L. Health benefits of oral contraceptives. Obstet Gynecol Clin North Am. 2000;27(4):705–721.
   PubMed Web of Science ®Google Scholar
• Cheslack-Postava K, Keyes KM, Lowe SR, et al. Oral contraceptive use and psychiatric disorders in a nationally representative sample of women. Arch Womens Ment Health. 2015;18(1):103–111.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Bravi F, Negri E, et al. Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update. 2009;15(5):489–498.
   PubMed Web of Science ®Google Scholar
• Liu H, Yao J, Wang W, et al. Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens. 2017;19(10):1032–1041.
   Web of Science ®Google Scholar
• Xu Z, Yue Y, Bai J, et al. Association between oral contraceptives and risk of hemorrhagic stroke: a meta-analysis of observational studies. Arch Gynecol Obstet. 2018;297(5):1181–1191.
   PubMed Web of Science ®Google Scholar
• Soroush A, Farshchian N, Komasi S, et al. The role of oral contraceptive pills on increased risk of breast cancer in Iranian populations: a meta-analysis. J Cancer Prev. 2016;21(4):294–301.
   PubMedGoogle Scholar
• Amoozegar F, Ronksley PE, Sauve R, et al. Hormonal contraceptives and cerebral venous thrombosis risk: a systematic review and meta-analysis. Front Neurol. 2015;6:7.
   PubMed Web of Science ®Google Scholar
• Kiley J, Hammond C. Combined oral contraceptives: a comprehensive review. Clin Obstet Gynecol. 2007;50(4):868–877.
   PubMed Web of Science ®Google Scholar
• Gabal LL, Goodman-Gruen D, Barrett-Connor E. The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus. Am J Public Health. 1997;87(3):443–445.
   PubMed Web of Science ®Google Scholar
• Espeland MA, Hogan PE, Fineberg SE, The Pepi Investigators, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Postmenopausal estrogen/progestin interventions. Diabetes Care. 1998;21(10):1589–1595.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Howard BV, Cowan LD, et al. The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in American Indian postmenopausal women : the strong heart study. Diabetes Care. 2002;25(3):500–504.
   PubMed Web of Science ®Google Scholar
• Kim C, Seidel KW, Begier EA, et al. Diabetes and depot medroxyprogesterone contraception in Navajo women. Arch Intern Med. 2001;161(14):1766–1771.
   PubMedGoogle Scholar
• Kim C, Siscovick DS, Sidney S, CARDIA Study, et al. Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary artery risk development in young adults. Diabetes Care. 2002;25(6):1027–1032.
   PubMed Web of Science ®Google Scholar
• Chasan-Taber L, Willett WC, Stampfer MJ, et al. A prospective study of oral contraceptives and NIDDM among U.S. women. Diabetes Care. 1997;20(3):330–335.
   PubMed Web of Science ®Google Scholar
• Rosenthal AD, Shu XO, Jin F, et al. Oral contraceptive use and risk of diabetes among Chinese women. Contraception. 2004;69(3):251–257.
   PubMed Web of Science ®Google Scholar
• Deleskog A, Hilding A, Östenson CG. Oral contraceptive use and abnormal glucose regulation in Swedish middle aged women. Diabetes Res Clin Pract. 2011;92(2):288–292.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Manson JE, Stampfer MJ, et al. Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women. Diabetologia. 1992;35(10):967–972.
   PubMed Web of Science ®Google Scholar
• Kim SW, Jeon JH, Lee WK, et al. Long-term effects of oral contraceptives on the prevalence of diabetes in post-menopausal women: 2007-2012 KNHANES. Endocrine. 2016;53(3):816–822.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S14–S31.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Papalou O, Kandaraki EA. The role of androgen excess on insulin sensitivity in women. Front Horm Res. 2019;53:50–64.
   PubMed Web of Science ®Google Scholar
• Godsland IF, Walton C, Felton C, et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 1992;74(1):64–70.
   PubMed Web of Science ®Google Scholar
• Kahn JA, Gordon CM. Polycystic ovary syndrome. Adolesc Med. 1999;10(2):321–336.
   PubMedGoogle Scholar
• Lemay A, Dodin S, Turcot L, et al. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance. Hum Reprod. 2006;21(1):121–128.
   PubMed Web of Science ®Google Scholar
• Amiri M, Ramezani Tehrani F, Nahidi F, et al. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism. 2017;73:22–35.
   PubMed Web of Science ®Google Scholar
• Podfigurna A, Meczekalski B, Petraglia F, et al. Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone). J Endocrinol Invest. 2020;43(4):483–492.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Soldani R, Carriero PL, et al. Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab. 1992;74(6):1396–1400.
   PubMed Web of Science ®Google Scholar
• Mandour T, Kissebah AH, Wynn V. Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity. Eur J Clin Invest. 1977;7(3):181–187.
   PubMed Web of Science ®Google Scholar
• Wei L. The types and side effects of female contraceptives. Chin J Mod Drug Appl. 2015;9:246–247.
   Google Scholar
• Cerel-Suhl SL, Yeager BF. Update on oral contraceptive pills. Am Fam Physician. 1999;60(7):2073–2084.
   PubMed Web of Science ®Google Scholar
• Chester RC, Kling JM, Manson JE. What the women's health initiative has taught us about menopausal hormone therapy. Clin Cardiol. 2018;41(2):247–252.
   PubMed Web of Science ®Google Scholar